{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:22:43Z","timestamp":1792650163466,"version":"4.5.0"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We evaluated the adjuvant effect of a modified glycoform of lipopolysaccharide (LPS) (LgtB-LpxL1) compared to that of the nonmodified glycoform Lpxl1 serogroup B meningococcal H44\/76 native outer membrane vesicles (nOMVs) on immune responses to vaccination with the recombinant meningococcal protein, rPorA, tetanus toxoid, or meningococcal serogroup C capsular polysaccharide. We used LgtB-LpxL1 LPS because the disruption of the<jats:italic>lgtB<\/jats:italic>gene, which results in the exposure of<jats:italic>N<\/jats:italic>-acetylglucosamine-galactose-glucose residues in the LPS outer core, has been shown to enhance the activation of human dendritic cells<jats:italic>in vitro<\/jats:italic>. The responses were compared to those of a monophosphoryl lipid A (MPL)-based adjuvant and to an aluminum hydroxide suspension. The nOMVs induced blood serum IgG responses against each of the three antigens comparable to those obtained with MPL or aluminum salt. However, nOMVs elicited (i) a lower IgG1\/IgG2a ratio against rPorA and (ii) serum bactericidal antibody titers superior to those achieved with aluminum salt, reaching similar titers to those obtained with MPL. Similarly, bactericidal antibody titers induced by immunization with meningococcal serogroup C polysaccharide and nOMVs were similar to those obtained using MPL but were better than those with aluminum salt. Immunization with tetanus toxoid and nOMVs resulted in tetanus toxoid-specific IgG responses similar to those obtained when adjuvanted with aluminum salt. These results highlight the potential utility of meningococcal LpxL1 LPS-containing nOMVs as an adjuvant for recombinant meningococcal protein vaccines and suggest their possible use with a variety of other antigens.<\/jats:p>","DOI":"10.1128\/cvi.00561-13","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T02:43:18Z","timestamp":1387420998000},"page":"234-242","source":"Crossref","is-referenced-by-count":26,"title":["Neisseria meningitidis Native Outer Membrane Vesicles Containing Different Lipopolysaccharide Glycoforms as Adjuvants for Meningococcal and Nonmeningococcal Antigens"],"prefix":"10.1128","volume":"21","author":[{"given":"Jerry C.","family":"Nagaputra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Claire","family":"Hoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojas Hrakesh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnstein","family":"Norheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Feavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Richard","family":"Moxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"key20180919073722_B1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.vaccine.2010.11.064","article-title":"Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1","volume":"29","author":"Brunelli","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073722_B2","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1016\/S0264-410X(01)00205-5","article-title":"Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6\u20138 October, 2000","volume":"19","author":"Cartwright","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073722_B3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"key20180919073722_B4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1073\/pnas.89.1.358","article-title":"Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy","volume":"89","author":"Fries","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073722_B5","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073722_B6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1128\/CVI.00038-06","article-title":"Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants","volume":"13","author":"Ruijne","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073722_B7","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"key":"key20180919073722_B8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"key20180919073722_B9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"key20180919073722_B10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/IAI.61.1.187-196.1993","article-title":"Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants","volume":"61","author":"Verheul","year":"1993","journal-title":"Infect. Immun."},{"key":"key20180919073722_B11","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.1073\/pnas.1104588108","article-title":"Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells","volume":"108","author":"MacLeod","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073722_B12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"key20180919073722_B13","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1016\/S0264-410X(01)00193-1","article-title":"Towards the rational design of Th1 adjuvants","volume":"19","author":"Moingeon","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073722_B14","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073722_B15","first-page":"323","article-title":"Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine","volume":"92","author":"Rosenqvist","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"key20180919073722_B16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073722_B17","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1016\/j.vaccine.2008.09.041","article-title":"Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures","volume":"26","author":"J\u00e4kel","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073722_B18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1086\/368360","article-title":"Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia","volume":"187","author":"Plested","year":"2003","journal-title":"J. Infect. Dis."},{"key":"key20180919073722_B19","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1128\/IAI.67.10.5417-5426.1999","article-title":"Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis","volume":"67","author":"Plested","year":"1999","journal-title":"Infect. Immun."},{"key":"key20180919073722_B20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1004","article-title":"Innate immune sensing and its roots: the story of endotoxin","volume":"3","author":"Beutler","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"key20180919073722_B21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0264-410X(98)00259-X","article-title":"Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine","volume":"17","author":"Naess","year":"1999","journal-title":"Vaccine"},{"key":"key20180919073722_B22","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073722_B23","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.4049\/jimmunol.177.6.4002","article-title":"Role of N-acetylglucosamine within core lipopolysaccharide of several species of gram-negative bacteria in targeting the DC-SIGN (CD209)","volume":"177","author":"Zhang","year":"2006","journal-title":"J. Immunol."},{"key":"key20180919073722_B24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1462-5822.2005.00623.x","article-title":"Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function","volume":"8","author":"Steeghs","year":"2006","journal-title":"Cell. Microbiol."},{"key":"key20180919073722_B25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2958.1995.mmi_18040729.x","article-title":"Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis","volume":"18","author":"Jennings","year":"1995","journal-title":"Mol. Microbiol."},{"key":"key20180919073722_B26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"key20180919073722_B27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1365-2958.2005.04838.x","article-title":"The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae","volume":"58","author":"Criss","year":"2005","journal-title":"Mol. Microbiol."},{"key":"key20180919073722_B28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF02173639","article-title":"Use of a non-selective transformation technique to construct a multiply restriction\/modification-deficient mutant of Neisseria gonorrhoeae","volume":"251","author":"Gunn","year":"1996","journal-title":"Mol. Gen. Genet."},{"key":"key20180919073722_B29","doi-asserted-by":"publisher","first-page":"e51045","DOI":"10.1371\/journal.pone.0051045","article-title":"Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine","volume":"7","author":"Sadarangani","year":"2012","journal-title":"PLoS One"},{"key":"key20180919073722_B30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1172\/JCI109383","article-title":"Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man","volume":"63","author":"Zollinger","year":"1979","journal-title":"J. Clin. Invest."},{"key":"key20180919073722_B31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/hv.1.2.1651","article-title":"Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry","volume":"1","author":"Vipond","year":"2005","journal-title":"Hum. Vaccin."},{"key":"key20180919073722_B32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0022-1759(90)90018-Q","article-title":"Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis","volume":"126","author":"Lesse","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"key20180919073722_B33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-61779-346-2_6","article-title":"Expression, purification, and crystallization of neisserial outer membrane proteins","volume":"799","author":"Saleem","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"key20180919073722_B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0022-1759(94)90204-6","article-title":"Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the toxin neutralization test in mice","volume":"168","author":"Manghi","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"key20180919073722_B35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JCM.29.7.1439-1446.1991","article-title":"Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay","volume":"29","author":"Plikaytis","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073722_B36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/1-59259-148-5:289","article-title":"Serogroup B and C serum bactericidal assays","volume-title":"Meningococcal vaccines. Methods and protocols","author":"Borrow","year":"2001"},{"key":"key20180919073722_B37","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"key":"key20180919073722_B38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00739.x","article-title":"The role of helper T cell products in mouse B cell differentiation and isotype regulation","volume":"102","author":"Coffman","year":"1988","journal-title":"Immunol. Rev."},{"key":"key20180919073722_B39","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/eji.1830201010","article-title":"Induction of antibody synthesis by CD4+ T cells: IL 5 is essential for induction of antigen-specific antibody responses by TH2 but not TH1 clones","volume":"20","author":"DeKruyff","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"key20180919073722_B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1099\/00222615-38-1-23","article-title":"Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins","volume":"38","author":"Wedege","year":"1993","journal-title":"J. Med. Microbiol."},{"key":"key20180919073722_B41","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073722_B42","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(09)61567-1","article-title":"Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years","volume":"374","author":"GlaxoSmithKline Vaccine HPV-007 Study Group","year":"2009","journal-title":"Lancet"},{"key":"key20180919073722_B43","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.vaccine.2007.12.038","article-title":"Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers","volume":"26","author":"Vandepapeli\u00e8re","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073722_B44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.170.1.194","article-title":"Toll-like receptor 2 ligands as adjuvants for human Th1 responses","volume":"170","author":"Sieling","year":"2003","journal-title":"J. Immunol."},{"key":"key20180919073722_B45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.20051540","article-title":"Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci","volume":"203","author":"Beninati","year":"2006","journal-title":"J. Exp. Med."},{"key":"key20180919073722_B46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1574-695X.2000.tb01460.x","article-title":"Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A\/C polysaccharide vaccine","volume":"28","author":"Borrow","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"key20180919073722_B47","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"key20180919073722_B48","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1016\/j.vaccine.2011.08.071","article-title":"Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073722_B49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1128\/CVI.00403-08","article-title":"Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2","volume":"16","author":"Koeberling","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073722_B50","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1016\/j.vaccine.2005.06.001","article-title":"Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives","volume":"23","author":"Arigita","year":"2005","journal-title":"Vaccine"},{"key":"key20180919073722_B51","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1128\/IAI.63.9.3473-3478.1995","article-title":"Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis","volume":"63","author":"Hoogerhout","year":"1995","journal-title":"Infect. Immun."},{"key":"key20180919073722_B52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"key20180919073722_B53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"key20180919073722_B54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073722_B55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/1753425910383999","article-title":"Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production","volume":"17","author":"Sprong","year":"2011","journal-title":"Innate Immun."},{"key":"key20180919073722_B56","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1128\/IAI.00005-08","article-title":"Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis","volume":"76","author":"Steeghs","year":"2008","journal-title":"Infect. Immun."},{"key":"key20180919073722_B57","first-page":"25","article-title":"Rough mutants of Salmonella Typhimurium: immunochemical and structural analysis of lipopolysaccharides from rfaH mutants","volume":"116","author":"Lindberg","year":"1980","journal-title":"J. Gen. Microbiol."},{"key":"key20180919073722_B58","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/intimm\/dxh264","article-title":"Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria","volume":"17","author":"Nagaoka","year":"2005","journal-title":"Int. Immunol."},{"key":"key20180919073722_B59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/intimm\/dxg019","article-title":"SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran","volume":"15","author":"Kang","year":"2003","journal-title":"Int. Immunol."},{"key":"key20180919073722_B60","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1128\/IAI.64.8.2998-3006.1996","article-title":"Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens","volume":"64","author":"de Vries","year":"1996","journal-title":"Infect. Immun."},{"issue":"Pt 11","key":"key20180919073722_B61","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1099\/00221287-145-11-3013","article-title":"The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis","volume":"145","author":"Jennings","year":"1999","journal-title":"Microbiology"},{"key":"key20180919073722_B62","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1016\/j.vaccine.2009.01.084","article-title":"Mechanism of action of licensed vaccine adjuvants","volume":"27","author":"Tritto","year":"2009","journal-title":"Vaccine"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00561-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:50:26Z","timestamp":1627591826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00561-13"}},"subtitle":[],"editor":[{"given":"M. F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,1,29]]},"published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1128\/CVI.00561-13"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00561-13","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}